Frailty and quality of life among older people with and without a cancer diagnosis: Findings from TOPICS-MDS

Abstract

BackgroundThe number of older cancer patients is rising. Especially in older people, treatment considerations should balance the impact of disease and treatment on quality of life (QOL) and survival. How a cancer diagnosis in older people interacts with concomitant frailty to impact on QOL is largely unknown. We aimed to determine the association between frailty and QOL among community-dwelling older people aged 65 years or above with and without a cancer diagnosis cross-sectionally and at 12 months follow-up.MethodsData were derived from the TOPICS-MDS database. Frailty was quantified by a frailty index (FI). QOL was measured with the subjective Cantril’s Self Anchoring Ladder (CSAL, range: 0–10) and the health-related EuroQol-5D (EQ-5D, range:-0.33–1.00) at baseline and after 12 months. To determine associations, linear mixed models were used.Results7493 older people (78.6±6.4 years, 58.4% female) were included. Dealing with a cancer diagnosis (n = 751) was associated with worse QOL both at baseline (CSAL:-0.25 (95%-CI:-0.36;-0.14), EQ-5D:-0.03 (95%-CI:-0.05;-0.02)) and at follow-up (CSAL:-0.13 (95%-CI:-0.24;-0.02), EQ-5D:-0.02 (95%-CI:-0.03;-0.00)). A ten percent increase in frailty was also associated with a decrease in QOL at baseline (CSAL:-0.35 (95%-CI:-0.38;-0.32), EQ-5D:-0.12 (95%-CI:-0.12;-0.11)) and follow-up (CSAL:-0.27 (95%-CI:-0.30;-0.24), EQ-5D:-0.07 (95%-CI:-0.07;-0.06)). When mutually adjusting for frailty and a cancer diagnosis, associations between a cancer diagnosis and QOL only remained significant for CSAL at baseline (-0.14 (95%-CI:-0.25;-0.03)), whereas associations between frailty and QOL remained significant for all QOL outcomes at baseline and follow-up. No statistical interactions between cancer and frailty in their combined impact on QOL were found.ConclusionsCancer diagnosis and frailty were associated with worse health-related and self-perceived QOL both at baseline and at follow-up. Differences in QOL between older people with and without a cancer diagnosis were explained to a large extent by differences in frailty levels. This stresses the importance to take into account frailty in routine oncologic care.

Health related quality of life in older patients with solid tumors and prognostic factors for decline

“…As a consequence, older patients are less willing to accept severe toxicity and reduced HRQOL. In non-fit older patients with cancer this may complicate treatment decisions even more because HRQOL decreases with increased frailty [13].…”

Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature

“…Of the remaining 915 publications, titles and abstracts were screened for eligibility, after which 54 articles remained for full‐text screening. A total of 26 unique FSTs were identified after full‐text evaluation 19–47 . A flow chart on the literature search and reasons for exclusion can be found in the Fig.…”

Comparing comorbidity scales: Attending physician score versus the Cumulative Illness Rating Scale for Geriatrics

“…A few other studies have investigated how frail older cancer patients perceive their QoL, and the findings are in line with our results. Frail patients seem to be at a considerable disadvantage throughout the disease trajectory, reporting a substantial symptom burden and poor functioning compared to non-frail patients [273][274][275][276][277]. We used QLQ-C30 for our assessments, and although this is generally regarded as an excellent QoL questionnaire, it is debatable whether it captures how the patients' health problems actually affect their quality of life in a broader sense.…”